MASSMUTUAL TRUST CO FSB/ADV - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2023$5,999
+34.5%
970.0%0.00%
Q3 2023$4,461
-20.0%
970.0%0.00%
Q2 2023$5,575
+53.2%
970.0%0.00%
Q1 2023$3,638
+121166.7%
970.0%0.00%
Q4 2022$3
-99.9%
970.0%0.00%
Q3 2022$3,000
-25.0%
97
-8.5%
0.00%
Q2 2022$4,000
+33.3%
106
+9.3%
0.00%
Q1 2022$3,000
+50.0%
970.0%0.00%
Q4 2021$2,000
-33.3%
97
-24.8%
0.00%
Q2 2021$3,0001290.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders